685 related articles for article (PubMed ID: 32433719)
1. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
Abid MB; Mughal M; Abid MA
JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
[No Abstract] [Full Text] [Related]
2. Palliative Care for Patients With Cancer in the COVID-19 Era.
Mehta AK; Smith TJ
JAMA Oncol; 2020 Oct; 6(10):1527-1528. PubMed ID: 32379855
[No Abstract] [Full Text] [Related]
3. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
[No Abstract] [Full Text] [Related]
4. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.
Cinar P; Cox J; Kamal A; Bickel K; Krzyzanowska M; Armitage J; Ganti AK; Ward J; Wong S; Lonial S; Bosserman L
JCO Oncol Pract; 2020 Aug; 16(8):431-434. PubMed ID: 32463764
[No Abstract] [Full Text] [Related]
5. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.
Figuero-Pérez L; Olivares-Hernández A; Escala-Cornejo RA; Cruz-Hernández JJ
JCO Oncol Pract; 2020 Jun; 16(6):348-349. PubMed ID: 32369410
[No Abstract] [Full Text] [Related]
6. Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk.
Lou E; Beg S; Bergsland E; Eng C; Khorana A; Kopetz S; Lubner S; Saltz L; Shankaran V; Zafar SY
JCO Oncol Pract; 2020 Jul; 16(7):383-388. PubMed ID: 32352884
[No Abstract] [Full Text] [Related]
7. Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19.
Gatto L; Franceschi E; Nunno VD; Brandes AA
Immunotherapy; 2020 Oct; 12(15):1111-1114. PubMed ID: 32594820
[No Abstract] [Full Text] [Related]
8. [COVID-19- what have we learned and where are we heading?].
Gudnason T
Laeknabladid; 2020 Oct; 106(10):449. PubMed ID: 32991305
[No Abstract] [Full Text] [Related]
9. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
Bergmann CC; Silverman RH
Cleve Clin J Med; 2020 Jun; 87(6):321-327. PubMed ID: 32366502
[No Abstract] [Full Text] [Related]
10. Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities.
Balogun OD; Bea VJ; Phillips E
JAMA Oncol; 2020 Oct; 6(10):1531-1532. PubMed ID: 32789508
[No Abstract] [Full Text] [Related]
11. COVID-19 and cancer: do we really know what we think we know?
Robinson AG; Gyawali B; Evans G
Nat Rev Clin Oncol; 2020 Jul; 17(7):386-388. PubMed ID: 32424196
[TBL] [Abstract][Full Text] [Related]
12. NCI's Work to Advance Cancer Research while Responding to the COVID-19 Pandemic.
Singer DS
Cancer Cell; 2020 Jun; 37(6):746-748. PubMed ID: 32425703
[TBL] [Abstract][Full Text] [Related]
13. The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer.
Rubinstein SM; Steinharter JA; Warner J; Rini BI; Peters S; Choueiri TK
Cancer Cell; 2020 Jun; 37(6):738-741. PubMed ID: 32454025
[TBL] [Abstract][Full Text] [Related]
14. Patients with cancer in the COVID-19 era: the clinical trial issue.
Scarcia M; Ludovico GM; Fortunato A; Fiorentino A
Tumori; 2020 Aug; 106(4):271-272. PubMed ID: 32508257
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 convalescent plasma: phase 2.
Knudson CM; Jackson JB
Transfusion; 2020 Jun; 60(6):1332-1333. PubMed ID: 32374890
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Meylan P
Rev Med Suisse; 2020 Nov; 16(714):2190-2191. PubMed ID: 33174706
[No Abstract] [Full Text] [Related]
17. Ten things we learned about COVID-19.
Cecconi M; Forni G; Mantovani A
Intensive Care Med; 2020 Aug; 46(8):1590-1593. PubMed ID: 32504103
[No Abstract] [Full Text] [Related]
18. The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond.
Bellanti JA; Settipane RA
Allergy Asthma Proc; 2020 Nov; 41(6):395-396. PubMed ID: 33109305
[No Abstract] [Full Text] [Related]
19. Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually.
Liu R; Sundaresan T; Reed ME; Trosman JR; Weldon CB; Kolevska T
JCO Oncol Pract; 2020 Jun; 16(6):289-293. PubMed ID: 32364826
[No Abstract] [Full Text] [Related]
20. Rethinking Clinical Trials Reform During the COVID-19 Pandemic.
Nabhan C; Choueiri TK; Mato AR
JAMA Oncol; 2020 Sep; 6(9):1327-1329. PubMed ID: 32761101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
